Tg launches 1 Bio, single-use biopharma scale-up hub

The IT Minister announced over `200 crore in new infrastructure upgrades by TGIIC

Hyderabad: In a major boost to India’s biologics and next-generation therapeutics ecosystem, Telangana, on Monday inaugurated 1 Bio, the nation’s first single-use bioprocess design and scale-up facility, marking a pivotal expansion of the Genome Valley innovation cluster. The facility was unveiled by Telangana’s Minister for IT, Electronics & Communications, and Industries & Commerce D Sridhar Babu, who described the launch as the “next wave of growth and leadership” for India’s biopharma sector.

Speaking at the event, Minister Sridhar Babu said, “As Genome Valley marks 25 years, we are setting the course for its next 25 years. 1 Bio is one of India’s most important steps toward democratising access to biologics scale-up and accelerating the journey from discovery to clinical readiness. With this facility, innovations can now advance to pilot and clinical stages in Hyderabad faster, more predictably, and at lower cost.”

To prepare Genome Valley for its next phase of expansion, the Minister announced over Rs200 crore in new infrastructure upgrades by TGIIC, including road widening, new greenfield roads, power augmentation, and landscaping and streetscaping improvements to enhance connectivity and ensure robust utility services within the cluster.

Special Chief Secretary (Industries & ITE&C) Sanjay Kumar highlighted Telangana’s dominant role in national and global life sciences output, noting that the State contributes 40 per cent of India’s pharma production and one-third of global vaccine supply. He said 1 Bio strengthens this leadership by giving innovators access to world-class bioprocess development capacity.

Related Posts

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore